Introduction
Mobious Biosystems is pioneering the development of fundamentally new technologies in the fields of genetic analysis and proteomics.
By unifying biological molecular systems and artificial nanostructures, Mobious has created a range of next generation diagnostic and research tools, able to materially outperform current platforms at a fraction of the cost.
The group’s research has resulted in new technologies and IP in such fields as single molecule sequencing, sequencing by synthesis, ultra highly multiplexed real-time PCR and affinity acceleration for biochips.
Mobious believes that its technology has the potential to help transform the acquisition and use of genetic knowledge in the global healthcare and detection industries.
Mobious Biosystems is pioneering the development of fundamentally new technologies in the fields of genetic analysis and proteomics.
By unifying biological molecular systems and artificial nanostructures, Mobious has created a range of next generation diagnostic and research tools, able to materially outperform current platforms at a fraction of the cost.
The group’s research has resulted in new technologies and IP in such fields as single molecule sequencing, sequencing by synthesis, ultra highly multiplexed real-time PCR and affinity acceleration for biochips.
Mobious believes that its technology has the potential to help transform the acquisition and use of genetic knowledge in the global healthcare and detection industries.
*************************************************************************************
Update - Nexus I, the worlds first and only 24hr Genome Sequencer. - Specifications available now